Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Conditions
Idiopathic Pulmonary Fibrosis (IPF)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Palmtree Clinical Research Inc., Palm Spring, California, United States
Paradigm Clinical Research Centers LLC, Redding, California, United States
Infinity Medical Research, North Dartmouth, Massachusetts, United States
Contact: Study coordinator (Curtis J Mello, MD) · lfernandes@infinitymedicalresearch.com · 508-998-3041Clinical Research Associates of Central PA, DuBois, Pennsylvania, United States
Contact: Study coordinator (Sandeep Bansal, MD, FCCP, FACP) · akansha@clinicalresearchassoc.com · 814-940-1212Clinical Research of Rock Hill, Rock Hill, South Carolina, United States
Clinical Trials Center of Middle Tennesee LLC, Franklin, Tennessee, United States
Premier Pulmonary Critical Care and Sleep Medicine, Denison, Texas, United States
Renovatio Clinical, The Woodlands, Texas, United States
Contact: Study coordinator (Ather Siddiqi, MD) · pablo.villarreal@renovatioclinical.com · 713-703-2398Renovatio Clinical, Webster, Texas, United States
Contact: Study coordinator (Alfred Maksoud, MD) · iryna.litvinenko@renovatioclinical.com · 713-703-2398